PfSPZ Malaria Vaccine Development Progress by Sanaria in Collaboration with LMIV and MRTC, Highlighted as One of 8 Top NIH Research Projects for 2021
The U.S. National Institutes of Health (NIH) just announced eight top research highlights/projects of 2021 and Sanaria’s PfSPZ-CVac malaria vaccine development efforts in collaboration with the NIH, National Institute of Allergy and Infectious Diseases (NIAID) Laboratory of Malaria, Immunology and Vaccinology (LMIV), and the Malaria Research Training Center (MRTC) in Bamako, Mali is one of the eight. Only two were from NIAID. The other was on COVID-19. This is incredible independent recognition of Sanaria’s progress and the promise of Sanaria’s vaccine program.
